Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients

MONDAY, Oct. 19, 2020 -- For about 20 percent of patients with neovascular age-related macular degeneration (nAMD), useful visual acuity (VA) is preserved with anti-vascular endothelial growth factor (VEGF) treatment, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news